Arcellx (ACLX) Revenue (2023 - 2025)

Arcellx (ACLX) recorded quarterly Revenue of $1.7 million in Q4 2025, down 66.24% quarter-over-quarter from $4.9 million in Q3 2025, and down 89.17% on a YoY basis from $15.3 million in Q4 2024.

Arcellx (ACLX) Revenue (2023 - 2025) Analysis & Trends

Arcellx's Revenue history runs 3 years deep, the most recent figure standing at $1.7 million for Q4 2025.

  • In Q4 2025, Revenue fell 89.17% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $22.3 million (down 79.36% YoY), while the FY2025 annual figure was $22.3 million, down 79.35% from the prior year.
  • Revenue was $1.7 million for Q4 2025 at Arcellx, down from $4.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $63.1 million in Q4 2023 to a low of $1.7 million in Q4 2025.
  • Historically, Revenue has averaged $20.0 million across 3 years, with a median of $15.1 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Revenue surged 119.16% in 2024, then plunged 89.17% in 2025.
  • A 3-year view of Revenue shows it stood at $63.1 million in 2023, then slumped by 75.83% to $15.3 million in 2024, then slumped by 89.17% to $1.7 million in 2025.
  • The last three Revenue figures came in at $1.7 million (Q4 2025), $4.9 million (Q3 2025), and $7.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - 1.65 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.65 Mn
Sep 30, 2025 4.90 Mn
Jun 30, 2025 7.60 Mn
Mar 31, 2025 8.13 Mn
Dec 31, 2024 15.27 Mn
Sep 30, 2024 26.03 Mn
Jun 30, 2024 27.38 Mn
Mar 31, 2024 39.26 Mn
Dec 31, 2023 63.15 Mn
Sep 30, 2023 14.96 Mn
Jun 30, 2023 14.30 Mn
Mar 31, 2023 17.91 Mn